Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial

MLA

Thomas Schmitz, et al. “Neonatal Outcomes for Women at Risk of Preterm Delivery given Half Dose versus Full Dose of Antenatal Betamethasone: A Randomised, Multicentre, Double-Blind, Placebo-Controlled, Non-Inferiority Trial.” The Lancet, vol. 400, Aug. 2022, pp. 592–604. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f000227a80ac7948995631645068baa1&authtype=sso&custid=ns315887.

APA

Thomas Schmitz, Muriel Doret-Dion, Loic Sentilhes, Olivier Parant, Olivier Claris, Laurent Renesme, Julie Abbal, Aude Girault, Héloïse Torchin, Marie Houllier, Nolwenn Le Saché, Alexandre J Vivanti, Daniele De Luca, Norbert Winer, Cyril Flamant, Claire Thuillier, Pascal Boileau, Julie Blanc, Véronique Brevaut, … Alexandre Lapillonne. (2022). Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. The Lancet, 400, 592–604.

Chicago

Thomas Schmitz, Muriel Doret-Dion, Loic Sentilhes, Olivier Parant, Olivier Claris, Laurent Renesme, Julie Abbal, et al. 2022. “Neonatal Outcomes for Women at Risk of Preterm Delivery given Half Dose versus Full Dose of Antenatal Betamethasone: A Randomised, Multicentre, Double-Blind, Placebo-Controlled, Non-Inferiority Trial.” The Lancet 400 (August): 592–604. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f000227a80ac7948995631645068baa1&authtype=sso&custid=ns315887.